Entrada Therapeutics
Sean O'Donnell is a Senior Research Associate specializing in Formulation and Analytical Chemistry at Entrada Therapeutics since June 2024. Prior to this role, Sean served as a Senior Research Associate at Intellia Therapeutics, Inc., from August 2021 to January 2024, where responsibilities included leading lipid nanoparticle synthesis support and assessing structure and composition activity relationships for various research programs. Earlier experience includes working as a Process Engineer at Integral Biosystems from November 2018 to August 2021, where Sean focused on formulation techniques and drug delivery development. Sean holds a Bachelor of Science degree in Chemical Engineering from the University of Massachusetts Amherst.
Entrada Therapeutics
2 followers
Entrada Therapeutics’ mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics.